Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

A protocol for the induction of eryptosis, programmed cell death in erythrocytes, using the calcium ionophore, ionomycin, is provided. Successful eryptosis is evaluated by monitoring the localization phosphatidylserine in the membrane outer leaflet. Factors affecting the success of the protocol have been examined and optimal conditions provided.

Abstract

Eryptosis, erythrocyte programmed cell death, occurs in a number of hematological diseases and during injury to erythrocytes. A hallmark of eryptotic cells is the loss of compositional asymmetry of the cell membrane, leading to the translocation of phosphatidylserine to the membrane outer leaflet. This process is triggered by increased intracellular concentration of Ca2+, which activates scramblase, an enzyme that facilitates bidirectional movement of phospholipids between membrane leaflets. Given the importance of eryptosis in various diseased conditions, there have been efforts to induce eryptosis in vitro. Such efforts have generally relied on the calcium ionophore, ionomycin, to enhance intracellular Ca2+ concentration and induce eryptosis. However, many discrepancies have been reported in the literature regarding the procedure for inducing eryptosis using ionomycin. Herein, we report a step-by-step protocol for ionomycin-induced eryptosis in human erythrocytes. We focus on important steps in the procedure including the ionophore concentration, incubation time, and glucose depletion, and provide representative result. This protocol can be used to reproducibly induce eryptosis in the laboratory.

Introduction

Programmed cell death in erythrocytes, also known as eryptosis, is common in many clinical conditions and hematological disorders. Eryptosis is associated with cell shrinkage and the loss of phospholipid asymmetry in the cell plasma membrane1,2. Loss of asymmetry results in the translocation of phosphatidylserine (PS), a lipid normally localized in the inner leaflet3,4, to the cell outer leaflet, which signals to macrophages to phagocytose and remove defective erythrocytes5,6,

Protocol

All human blood samples used in the protocol described below were purchased as de-identified samples. No human subjects were directly involved or recruited for this study. The guidelines of the Declaration of Helsinki should be used when research involves human subjects.

1. Erythrocyte isolation from whole blood

  1. Add 500 µL of whole blood in acid citrate dextrose (ACD) (stored at 4 °C) to a microcentrifuge tube.
    NOTE: Whole blood was purchased in ACD. According to t.......

Representative Results

Optimization of ionomycin concentration

While ionomycin is required to induce eryptosis, increased ionomycin concentrations can lead to hemolysis (i.e. lysis of erythrocytes and release of hemoglobin), which needs to be avoided. Treatment of erythrocytes with 1 µM ionomycin in Ringer solution for 2 h is enough to induce eryptosis, as evidenced by successful labeling with annexin-V Alexa Flour 488 conjugate .......

Discussion

The goal of this procedure is to provide optimal values for ionophore concentration, treatment time, and extracellular glucose concentration, which are important factors in ensuring successful induction of eryptosis. A critical step in the protocol is the depletion of extracellular glucose, which, despite its importance, has not been sufficiently emphasized in the literature. The sugar content in normal Ringer solution (5 mM) has an inhibitory effect on eryptosis. Glucose depletion in the extracellular environment induce.......

Acknowledgements

This work was supported by NIH grant R15ES030140 and NSF grant CBET1903568. Financial support from the Russ College of Engineering and Technology and the Department of Chemical and Biomolecular Engineering at Ohio University is also acknowledged.

....

Materials

NameCompanyCatalog NumberComments
96-well plateFisher Scientific12-565-331
Annexin V Alexa Fluor 488 - apoptosis kitFisher ScientificA10788Store at 4 °C
BD FACSAria II flow cytometerBD Biosciences643177
CaCl2Fisher ScientificC79-500
CentrifugeMillipore SigmaM7157Model Eppendorf 5415C
Confocal fluorescence microscopyZeiss, LSM Tek ThornwoodModel LSM 510, Argon laser excited at 488 nm for taking images
Cover glasses circlesFisher Scientific12-545-100
Disposable round bottom flow cytometry tubeVWRVWRU47729-566
DMSOSigma-Aldrich472301-100ML
DPBSVWR Life ScienceSH30028.02
Glucose monohydrateSigma-AldrichY0001745
HEPES Buffer (1 M)Fisher Scientific50-751-7290Store at 4 °C
Ionomycin calcium saltEMD Milipore Corp.407952-1MGDissolve in DMSO to reach 2 mM. Store at -20 °C
KClFisher ScientificP330-500
MgSO4Fisher ScientificM65-500
Microcentrifuge tubeFisher Scientific02-681-5
NaClFisher ScientificS271-500
Plain glass microscope slidesFisher Scientific12-544-4
Synergy HFM microplate readerBioTek
Whole blood in ACDZen-BioStore at 4 °C and warm to 37 °C prior to use

References

  1. Bratosin, D., et al. Programmed Cell Death in Mature Erythrocytes: A Model for Investigating Death Effector Pathways Operating in the Absence of Mitochondria. Cell Death and Differentiation. 8 (12), 1143-1156 (2001).
  2. Lang, E., Lang, F.

Explore More Articles

EryptosisRed Blood CellsCalcium IonophoreIonomycinRinger SolutionGlucose free BufferHematocritCell SuspensionCentrifugationIncubation

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved